These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23454692)
1. Concentration and activity of the soluble form of the interleukin-7 receptor α in type 1 diabetes identifies an interplay between hyperglycemia and immune function. Monti P; Brigatti C; Krasmann M; Ziegler AG; Bonifacio E Diabetes; 2013 Jul; 62(7):2500-8. PubMed ID: 23454692 [TBL] [Abstract][Full Text] [Related]
2. IL-7 induces sCD127 release and mCD127 downregulation in human CD8 Côté SC; Burke Schinkel SC; Berthoud TK; Barros PO; Sanchez-Vidales M; Davidson AM; Crawley AM; Angel JB Eur J Immunol; 2020 Oct; 50(10):1537-1549. PubMed ID: 32390135 [TBL] [Abstract][Full Text] [Related]
6. Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection. Crawley AM; Faucher S; Angel JB J Immunol; 2010 May; 184(9):4679-87. PubMed ID: 20304824 [TBL] [Abstract][Full Text] [Related]
7. Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent. Barros PO; Berthoud TK; Aloufi N; Angel JB Immunotargets Ther; 2021; 10():47-62. PubMed ID: 33728276 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD127 potentiates IL-7 activity in vivo in healthy mice. Aloufi NA; Ali AK; Burke Schinkel SC; Molyer B; Barros PO; McBane JE; Lee SH; Angel JB Immun Inflamm Dis; 2021 Dec; 9(4):1798-1808. PubMed ID: 34525268 [TBL] [Abstract][Full Text] [Related]
9. IL-17 immunity in human type 1 diabetes. Honkanen J; Nieminen JK; Gao R; Luopajarvi K; Salo HM; Ilonen J; Knip M; Otonkoski T; Vaarala O J Immunol; 2010 Aug; 185(3):1959-67. PubMed ID: 20592279 [TBL] [Abstract][Full Text] [Related]
10. Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes. Yang JH; Cutler AJ; Ferreira RC; Reading JL; Cooper NJ; Wallace C; Clarke P; Smyth DJ; Boyce CS; Gao GJ; Todd JA; Wicker LS; Tree TI Diabetes; 2015 Nov; 64(11):3891-902. PubMed ID: 26224887 [TBL] [Abstract][Full Text] [Related]
11. Association of single-nucleotide polymorphisms in tumour necrosis factor and human leukocyte antigens genes with type 1 diabetes. Osman AE; Brema I; AlQurashi A; Al-Jurayyan A; Bradley B; Hamza MA Int J Immunogenet; 2021 Aug; 48(4):326-335. PubMed ID: 34018329 [TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes. Herold KC; Bucktrout SL; Wang X; Bode BW; Gitelman SE; Gottlieb PA; Hughes J; Joh T; McGill JB; Pettus JH; Potluri S; Schatz D; Shannon M; Udata C; Wong G; Levisetti M; Ganguly BJ; Garzone PD; JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852846 [TBL] [Abstract][Full Text] [Related]
14. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells. Faller E; Kakal J; Kumar R; Macpherson P Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839 [TBL] [Abstract][Full Text] [Related]
15. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization. Li CR; Deiro MF; Godebu E; Bradley LM J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722 [TBL] [Abstract][Full Text] [Related]